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Abstract
Pseudomonas aeruginosa (P.aeruginosa) remains a prominent nosocomial pathogen
responsible for high morbi-mortality in intensive care units (ICUs). P.aeruginosa transmis-
sion is known to be partly endogenous and exogenous. Main factors have been highlighted
but the precise role of environment in regard to antibiotics use remained unclear.
Objective
To assess the role of environment, medical care and individual risks factors for P. aeruginosa
colonization and infection.
Study design and setting
A French multicentric prospective study involved ten ICUs for a five months period. Every adult
patient newly hospitalized in ICUs with no P. aeruginosa carriage up to 48 hours after admis-
sion was included and weekly screened before discharge or death. Screening swabs were
either rectal, sputum or oropharyngeal samples. Hydric environment was also sampled each
week. Data on patient clinical features, environmental and device exposures, and antibiotics
supports were regularly collected. Multivariate analysis was performed with a multistate model.
Results
The overall prevalence of P. aeruginosa carriage was 15.3% (201/1314). Risk factors associ-
ated with patient colonization were: use of inactive antibiotics against P. aeruginosa (HR = 1.60
[1.15–2.21] p<0.01), tap water contamination at the entry in the room (HR = 1.66 [1.01–2.27]
p<0.05) and mechanical invasive ventilation (HR = 4.70 [2.66–8.31] p<0.0001). Active antibiot-
ics prevented from colonization (HR = 0.67 [0.48–0.93] p = 0.02) and from infection (HR = 0.64
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Conclusion
Hydric contamination and antibiotics pressure seem to remain key independent risk factors
in P. aeruginosa colonization. These results advocate the need to carry on preventive and
targeted interventions toward healthcare associated infections.
Introduction
Despite persistent and constant efforts made in Healthcare associated infections prevention,
cross infections remain an issue especially in intensive care units (ICU). In 2012, 23% of
patients acquired a healthcare associated infection during their hospitalization in an ICU that
is a risk four times higher than in other hospital units [1].
Cross infections are associated with high mortality rates and higher costs by complicating
patients’ cares and lengthening hospital stay [2–5].
Pathogens responsible for those infections are often multi-drug resistant (MDR) bacteria.
Among those pathogens, Pseudomonas aeruginosa is often encountered [6] and is responsible
for severe infections, difficult to manage, such as ventilator associated pneumonia, bacteremia
or skin infections, mainly in immunocompromised patients [7] with already a poor baseline
prognosis. Indeed this bacteria, once it has colonized the patient digestive mucosa or skin, can
lead to infections by immune deficiency and skin or mucosa breach by indwelling invasive
device for example. When focusing on the bacteria strains it seems that P.aeruginosa related
infections are more likely to occur to P.aeruginosa colonized patients, which highlights the
link between the two conditions [8–9].
P.aeruginosa transmission is known to be partly endogenous and exogenous but the precise
roles of one and another remain uncertain. Human digestive flora has been described as the
main source of endogenous transmission that can be enhanced by antibiotic pressure [8].
Hydric environment such as faucets, invasive devices exposure and other colonized patients
are responsible for exogenous transmission. Medical staff has been identified as a key carrier
from patients to patients (cross-transmission) [10]. Although genotyping methods allow track-
ing the spread of bacteria, the respective contribution of the various factors remains unclear.
Hence, the factors associated with P.aeruginosa colonization or infection are variable from
one study to another [11] including: length of hospitalization [12] severity of underlying dis-
ease [12–14] exposure to invasive procedures[13–15], contamination of water tap [12,16–18],
close contact with contaminated patients [14], antibiotic selective pressure [16–17]. The het-
erogeneity of the factors reported is due partly to the complexity of the measurement of expo-
sures, the definition of the outcome and of the methods used for the analysis of the association
with P.aeruginosa colonization or infection. In a previous report, we identified individual risk
factors and environmental factors associated to P.aeruginosa acquisition in a cohort of 1314
patients hospitalized in ICU in France [19]. However, we did not distinguish between coloni-
zation and infection, both were merge in the same outcome although factors could be different
in the two situations with different clinical consequences. The aim of our study was to assess
the distinct role of environment, antibiotic and patient condition toward both colonization
and infection, and to identify an interaction between environment and antibiotic selective
pressure.
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Materials and methods
Study setting
In 2009, an observational prospective multicentric study, entitled DYNAPYO, was performed,
involving ten French ICUs for a five months study period. There were two surgical, four medi-
cal and four mixed ICUs (both medical and surgical units). Six university hospitals (Besançon,
Bordeaux, Garches, Lyon, Montpellier and Paris) and two general hospitals (Lens and Tour-
coing) took part in the study and included each one ICU, excepted for Besançon and Lyon
which included two ICUs. These ICUs amounted between 9 and 20 beds and between 10 and
47 water taps. Data collection regarding environment and patient population was performed
by trained healthcare professionals and was registered into a secure online electronic form.
Sample size
In 2006 a pilot study was performed. In that study, the patients exposed to hydric contamina-
tion had a P.aeruginosa acquisition risk of 1.7. Within 6 months, the incidence of P.aeruginosa
acquisition was 5.7%. To confirm such size effect with a statistical power of 80% and type I
error of 5%, at least 112 events should be recorded. According to the expected incidence, it
required to include around 2000 patients. However, the present study was stopped prema-
turely because the incidence of acquisition was higher than expected. Every newly hospitalized
adult patient in ICUs with no P.aeruginosa carriage within the 48 first hours after admission
was included. No P.aeruginosa carriage means that samples (rectal oropharyngeal or sputum
swabs) were found negative at admission and within the 48 first hours. During the follow-up
period, they were weekly screened (rectal oropharyngeal or sputum swabs) until they died or
were discharged. Data were collected through medical record review: those about clinical and
medical conditions and prior antibiotic use were collected at admission, and follow-up data
such as hydric environment pressure, indwelling invasive device exposure and antibiotic sup-
port were regularly recorded.
To estimate the hydric environment pressure, faucets were weekly sampled in the morning
before use and disinfection. Specific sample protocol has been described in the previous report
[19]. No hygiene protocol modification could happen within the study period because of these
results as the units were blinded.
Samples were then analyzed by the bacteriology laboratories where aerobic cultures were
performed.
Data were made anonymous. All patients were informed of the survey and their rights.
Signed consents were not required. Local ethical committee [Comité Consultatif sur le Traite-
ment de l’Information en matière de Recherche dans le domaine de la Santé (CCTIRS) et
Commission de l’Informatique et des Libertés (CNIL)] approved the study.
Determination of colonization and infection
The first patient colonization and the first patient infection by P.aeruginosa were the two out-
comes of interest. Patient colonization was defined as the presence of P.aeruginosa among at
least one of the screening sample site from the 48th hour until discharge. If any colonization
was identified within the 48th hour, patients were considered as imported cases and were not
included in the analysis but still considered in exposure factor calculation. Colonization status
was unknown for healthcare workers so that no change in usual isolation procedure occurred
during the study.
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Patient infection was defined according to current recommendations from REA-RAISIN
network [20], as clinical and biological infection features associated with the isolation of the
bacteria in any samples (blood culture, urine culture. . .).
Main exposure factors
We focus on two exposure factors of main interest. First, hydric environment pressure was
measured by sampling performed at the faucets located in the patient room: Tap water con-
tamination at the entry in the patient room was the first main exposure factor. Antibiotic treat-
ments prescribed since the day before, were the second main exposure factor and were daily
recorded. We distinguished exclusive inactive antibiotics from active antibiotics against P.aer-
uginosa which includes at least one of the following: ureido and carboxypenicillins, antipseu-
domonal cephalosporins, carbapenems, colimycin fosfomycin, fluoroquinolones, and
aminoglycosides. The antibiotic activity was determined by the theoretical sensivity of antibi-
otics on a wild-type P.aeruginosa.
Other risk factors
Other individual risk factors were: age, sex, immucompromized status, IGSII score (i.e patient
disease severity at the admission in ICUs predicting mortality), Charlson comorbidity index
for chronic disease, cause of admission, prior antibiotics prescription before admission, prior
hospitalization within the year prior to admission, history of prior carriage of P.aeruginosa (i.e
prior colonization or diagnostic of P.aeruginosa infection). Environment risk factors were: any
specialization of the ICU (medical, surgical or mixed), center and prior occupation by a colo-
nized patient before entry in the room. Risk factors associated with medical care were: invasive
mechanical ventilation exposure and broncho-endoscopy exposure.
Statistical analysis
Analysis was performed with a multi-state model that included five states and eight transitions
(Fig 1). Baseline state 1—Hospitalization was the baseline status of patients hospitalized with-
out colonization nor infection. States 2—Colonization and 3—Infection reflected the occur-
rence of the first episode of colonization and infection. We assumed that the state 3—Infection
was systematically preceded by the state 2—Colonization. Arrows represent transitions from a
state to another. The model assumed that transitions were markovian, which means that his-
tory of past states (i.e. duration in the state) was not taken into account in the estimation [21].
A discrete non-homogeneous model was assumed: discrete because time unit is the day; non-
homogeneous because time-dependent variables were used as adjustment variables [22].
Fig 1. Multistate model representation.
https://doi.org/10.1371/journal.pone.0193300.g001
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We estimated the associations between risk factors and events of interest by modelling tran-
sition intensities. The transition intensities represent the instantaneous risk of going from one
state to another (e.g. acquiring infection from carrying P.aeruginosa).
Analyses were performed with the package “MSM” developed by C. Jackson in the R1 soft-
ware [23]. Weekly screenings for both patients and water taps led to interval censoring which
was taken into account by the model. Hydric environment exposure was assumed to be con-
stant between two screenings. In case of punctual missing values regarding follow-up data, the
package allows missing at random (MAR) imputation; in case of baseline or all along missing
data, patients were removed from analyses. To minimize loss of patients, conditional imputa-
tion procedure was implemented to replace missing data for IGSII score, history of prior car-
riage of P.aeruginosa, prior hospitalization within the year prior to admission and prior
antibiotics prescription before admission. To answer the aims of the study, we ran the model
transition by transition with the following order of interest: “Hospitalization-Colonization”,
“Colonization-Infection”, “Colonization-Death”, “Infection-Death” and “Hospitalization-
Death”. We did not focus on the transition to discharge, as the event was only considered as a
competing risk.
We first performed an univariable analysis including ten baseline factors and six binary
time-dependent factors in each transition. Our three main exposure factors were forced in the
model whatever their association, apart from hydric environment pressure which was specifi-
cally studied in the transition to colonization for the sake of clinical plausibility. We performed
a multivariable analysis including significant variables with a p-value<25% using a step-by-
step forward approach for each transition (p<5%). Adjustment for site was performed and we
evaluated the interactions between hydric environment and both active and inactive antibiot-
ics selective pressure in the final model in the transition leading to colonization. Hazard ratios
and their 95% confidence intervals were provided as well as likelihood ratio test p-values. Log-
linearity of the risk for quantitative variables has been checked.
Results
Study population
In the DYNAPYO cohort, 1700 patients were newly hospitalized, including 1314 P.aeruginosa-
free patients who were enrolled in the study. Patients characteristics are shown in Tables 1 and 2.
The median age was 59 years and 11% of patients were immunocompromised. The median
IGSII score was 42 points (Interquartile Range IQR: 30; 56). The median (IQR) length of stay
was 6 days (3; 13) and 232 patients (17.7%) died in a median delay of 7.5 days (3; 15). First col-
onization and first infection were respectively estimated to occur at 10 days (7; 16) and 12 days
(8; 19). During the follow-up, 70% were mechanically ventilated and among them, almost 90%
were ventilated at the admission.
A total of 855 positive hydric environment samples among 4999 screened were positive for
P. aeruginosa (17.1%).
Colonization and infection incidences
Among the 1314 patients, 201 patients were colonized during a total of 11 915 days follow-up,
corresponding to an incidence of 16.9 colonizations per 1000 patient-days (95%CI [14.6–19.2]).
An infection was observed in 87 patients during a 12 608 days of follow-up, representing
43.3% of P.aeruginosa carriers and an incidence of 6.9 infections per 1000 patient-days (95% CI
[5.5–8.3]).
Pseudomonas aeruginosa in intensive care units
PLOS ONE | https://doi.org/10.1371/journal.pone.0193300 March 9, 2018 5 / 12
Risk factors analysis
1305 patients were included in the analysis in the state 1–Hospitalization whereas 9 patients
were excluded from this analysis because of missing data for one or more variables. Among
the 1305 patients, 180+200+914 moved to another state, meaning that 11 stayed in the state 1–
Hospitalization at the end of the study (right-censoring). Also two and four patients stayed
Table 1. Patients characteristics at admission. Dynapyo cohort, France 2009.
Patient characteristics Included patients (n = 1314)




















Prior antibiotic administration before admission
Active antibiotics 51 3.9
Inactive antibiotics 187 14.2
Active and inactive antibiotics 136 10.4




Acute respiratory insufficiency 367 27.9
Septic shock 176 13.4
Others 383 29.2
Intensive care unit (ICU)
Medical ICU 604 46.0
Surgical ICU 179 13.6
Mixed ICU 531 40.4
Patient characteristics Included patients (n = 1314)
Total Median (IQR)
Age (in years) 1314 59 (43–73)
IGS-II score at admission 1284 42 (30–56)
CHARLSON index 1314 1 (0–3)
https://doi.org/10.1371/journal.pone.0193300.t001
Pseudomonas aeruginosa in intensive care units
PLOS ONE | https://doi.org/10.1371/journal.pone.0193300 March 9, 2018 6 / 12
respectively in the states 2–Colonization and 3–Infection at the end of the study and were
right-censored. Fig 2 shows the evolution of those 1305 patients during hospitalization.
Table 3 shows the main results after adjustment for the site.
The risk of colonization was significantly increased when inactive antibiotic were prescribed
(HR = 1.60; 95%CI = [1.15–2.21]), whereas it was decreased when active antibiotic were pre-
scribed (HR = 0.67; 95%CI = [0.48–0.93]). Tap water contamination at the entry in the patient
room enhanced the risk of colonization by +66% (HR = 1.66; 95%CI = [1.01–2.75]). History of P.
aeruginosa carriage and invasive ventilation were also significant independent risk factors of P.
aeruginosa colonization: HR = 4.03; 95%CI = [1.96–8.27] and HR = 4.70; 95%CI = [2.66–8.31],
respectively. Tests for interactions between the hydric environment and inactive or active anti-
biotics were not statistically significant (p-values 0.28 and 0.78, respectively).
The factors associated with P.aeruginosa infection were limited. Among colonized patients,
the prescription of active antibiotic tended to be associated with a lower risk of infection
occurrence (HR = 0.64; 95%CI = [0.41–1.01]). There was no significant association with inac-
tive antibiotic support (HR = 0.77; 95%CI = [0.47–1.26]).
Older age (HR = 1.12; 95%CI = [1.01–1.23]) increased the risk of death during hospitaliza-
tion. Whatever the colonized status, a higher IGSII score (HR = 1.46; 95%CI = [1.34–1.60] and
HR = 1.33; 95%CI = [1.06–1.66]) and the diagnosis of coma (HR = 1.79; 95%CI = [1.13–2.84]
and HR = 3.69; 95%CI = [1.20–11.33]) were associated with an increased risk of death.
Table 2. Exposure characteristics during the follow-up. Dynapyo cohort, France 2009.
Exposure characteristics Included patients (n = 1314)
Total Proportion in %
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Discussion
In an endemic situation, this study showed the constant presence and role played by P aerugi-
nosa with incidence density rates of 16.9 colonizations and 6.9 infections per 1000 patient-days.
Fig 2. Multistate model and number of subjects switching from one state to another. By definition, the 1305
patients started their hospitalization in state 1–hospitalization. nij: number of patients moving from state i to state j.
https://doi.org/10.1371/journal.pone.0193300.g002
Table 3. Multistate model after adjustment for the site: Risk factors for P. aeruginosacolonization, infection and risk factors for death. DYNAPYO Cohort–2009.
Variables Hospitalization–Colonization Colonization–Infection
(n1 = 1305) (n2 = 200) (n2 = 200) (n3 = 86)
HR 95%CI p-value HR 95%CI p-value
Contaminated hydric environment exposure at the entry room 1.66 1.01–2.75 <0.05
Active antibiotics exposure 0.67 0.48–0.93 0.02 0.64 0.41–1.01 <0.05
Inactive antibiotics exposure 1.60 1.15–2.21 <0.01 0.77 0.47–1.26 0.30
Prior P.aeruginosa carriage 4.03 1.96–8.27 <0.01
Invasive mechanical ventilation 4.70 2.66–8.31 <0.0001
Variables Hospitalization–Death Colonization–Death Infection–Death
(n1 = 1305) (n4 = 180) (n2 = 200) (n4 = 30) (n3 = 86) (n4 = 22)
HR 95%CI p-value HR 95%CI p-value HR 95%CI p-value
Active antibiotics exposure 0.65 0.47–0.90 <0.01 0.41 0.19–0.87 0.02 1.67 0.35–8.07 0.51
Inactive antibiotics exposure 0.83 0.60–1.14 0.24 0.86 0.36–2.04 0.77 0.66 0.25–1.71 0.41
Age (% 10 years) 1.12 1.01–1.23 0.03
IGS II score up to 24 hours (% 10 points) 1.46 1.34–1.60 <0.0001 1.33 1.06–1.66 0.01
Admission diagnosis (ref.Others) 0.06 0.02
Coma 1.79 1.13–2.84 3.69 1.20–11.33
Acute respiratory distress 1.21 0.75–1.96 2.06 0.66–6.41
Septic shock 1.16 0.70–1.92 0.51 0.10–2.68
HR = Hazard ratio
95% CI = 95% Confidence interval
p-value: obtained with Likehood ratio test
Interactions:
Contaminated hydric environment Active antibiotics exposure p = 0.78
Contaminated hydric environment Inactive antibiotics exposure p = 0.28
https://doi.org/10.1371/journal.pone.0193300.t003
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Hydric environment was identified as a consistent and independent risk factor, but also individ-
ual and health risk factors such as prior carriage of the bacteria, mechanical ventilation and anti-
biotic use were found to contribute to the transmission of the bacteria. No interaction between
antibiotic use and hydric environment contamination was detected. Therefore, an inappropri-
ate prescription of antibiotics does not seem to increase the risk of contamination by the hydric
environment.
These results highlighted the consistent role of the hydric environment in P.aeruginosa
transmission and the independent effect of both active and inactive antibiotics support in colo-
nization occurrence. The prevalence of colonized tap water was of 17.1%, quite similarly in
others studies [24]. Our results on risk factors are consistent with those from previously pub-
lished studies [13,16,18,25,26]. Environment has been identified as a major risk factor in the
exogenous transmission. Petignat et al. have shown the impact of infection control measures
targeting faucets toward P.aeruginosa colonization [27]. Prior carriage of P.aeruginosa and
mechanical ventilation were also found as important risk factors [11]. Active antibiotics are
described as protective factors [14,17,28], whereas inactive antibiotics have already been iden-
tified as risk factors [8,16]. In the present study, the antibiotics activity was defined according
to the theoretical knowledge of the effect of each molecule and not by the antibiogram for any
participant. This could represent an important limit in our study. However, the observed
opposite effects of active and inactive antibiotics is expected: inactive antibiotics, involving an
unbalance of the digestive microflora can indeed allow the bacteria to proliferate, in contrary
to active antibiotics which remove the bacteria.
Although we did not find any evidence for an interaction between the environment and
antibiotics, it does not mean that there was none. Either there is no interactive role between
antibiotics and environment, or there is one which could have been missed by a lack of statisti-
cal power or by an ignoring confounding factor.
Routine screening for P.aeruginosa carriage is not recommended [29], but this could be
questionned: first we identified prior P.aeruginosa carriage as a risk factor which could be
linked to clinical predisposition to acquire the bacteria once again. Second, we found that 43%
of colonized patients developed infectious conditions, and these results are consistent with
Gomez-Zorilla et al. [8] who ascertained that infections occurred much frequently among col-
onized than non-colonized patients (39% vs 3.4% p<0.001). Third, we highlighted the protec-
tive role of active antibiotics and featured that deaths occurred more likely with infected
patients (22/86) than colonized patients (30/200). Thus, according to medical history and con-
dition, for example for immunocompromised patients or among those that received common
antibiotics (which are mainly inefficient against the bacteria), this screening associated with
genotyping resistance test, could avoid delayed efficient antibiotics and so, avoid death [30].
Thanks to the use of multistate model that allows to distinguish colonization from infection,
we could demonstrate that indeed very few factors were associated with the risk of infection:
the exposure to active antibiotic especially. Also, usual risk factors of death were isolated (age,
IGSII, coma).
Furthermore as we carefully checked the link between anterior contaminated samples in
faucets and patient incident colonization, these results strengthen what we found in the risk
factors analysis.
Although a seven days interval screening seems to be a good compromise between feasibil-
ity and costs [24,26], test performances with a moderate sensitivity [31] and number of screen-
ing samples could have led to classification error. Colonization incidence could have been
overestimated because of wrong inclusion of unknown P.aeruginosa carriers who had been
then identified as incident cases. Hence this could explain the association between prior car-
riage of P.aeruginosa and colonization. Also, water tap sampling was also weekly collected and
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previous notes can also be applied: water tap status was considered constant until the next
screening. This situation has probably led to a decrease of the association between water tap
pressure and colonization or infection. However, a more intense screening is difficult to orga-
nize. Future studies may take advantage of new technologies such as the i-BIRD project [10] in
which spatio-temporal data of contact between healthcare workers are measured by sensitive
sensors.
In conclusion, hydric contamination and antibiotics pressure seem to remain key indepen-
dent risk factors in P.aeruginosa colonization. These results advocate the need to carry on pre-
ventive and targeted interventions toward healthcare associated infections. This study
encourages the settlement of cautious healthcare associated infections prevention measures
such as hands hygiene, respect of aseptic rules and more regular faucets maintenance.
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